# FDA Inspection 1025643 - Biomat USA Inc - September 07, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6747d83d-2a5d-422c-863a-da62d79a8df7
Source feed: FDA_Inspections

> FDA Inspection 1025643 for Biomat USA Inc on September 07, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025643
- Company Name: Biomat USA Inc
- Inspection Date: 2017-09-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261012 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/63acd4a0-ab89-42c1-a678-72516ba501ee)
- [FDA Inspection 1261012 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1730c069-7a15-468e-a1d1-d5d14f8795fa)

Company: https://www.keypedia.com/companies/biomat-usa-inc/424b9b98-28b3-4a57-9255-d597bdb012bc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d